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Fine Mapping of the Human Renal Oncocytoma- 
Associated Translocation (5;ll)(q35;ql3) Breakpoint
Richard J. Sinke, Trynie Dijkhuizen, Bert Janssen, 
Daniël Olde Weghuis, Gérard Merkx, Eva van den Berg, Ed Schuuring, 
Aurelia M. Meloni, Bauke de Jong, and Ad Geurts van Kessel
ABSTRACT: Recent cytogenetic analysis of a series of human renal oncocytomas revealed the presence 
of a recurring chromosomal translocation (5;ll)(q35;ql3) as sole anomaly in a subset of the tumors. The 
molecular characterization of this translocation was initiated using two primary t(5;ll)-positive renal 
oncocytomas and a panel of soma tic cell hybrids derived from one of these tumors, in conjunction with 
fluorescence in situ hybridization (FISH) and Southern blot analysis. The breakpoint in chromosome 
band l l q l 3  could be located within a genomic interval of at maximum 400 Kb immediately centromeric 
to the BCLl locus. © Elsevier Science Inc., 1997
INTRODUCTION
Oncocytomas are benign tumors that occur predominantly 
in the kidney, accounting for approximately 5% of all pri­
mary tumors at that site. Histologically, oncocytomas are 
characterized by the presence of epithelial cells with a strong 
granular eosinophilic cytoplasm. Ultras true tural examina­
tion revealed that these so-called oncocytic cells are 
densely packed with mitochondria, many of which show 
abnormal morphologic characteristics [l]. This phenotype, 
however, also can be found in some of the malignant neo­
plasms of the kidney such as the granular and chromopho­
bic variants of renal cell carcinomas [2], Although long­
term follow-up studies have shown that oncocytomas do 
not metastasize, several reports indicate the invasive 
potential of these tumors [3-5]. Preliminary cytogenetic 
studies performed on a limited series of renal oncocyto­
mas have revealed a heterogeneous chromosomal constitu­
tion [3, 5-7] Basically, two subgroups can be distinguished:
[1) those with numerical anomalies, including -Y and -1 
[8-10]; and (2) those with recurring structural anomalies, 
in particular t(5;ll)(q35;ql3) [11, 12] or variants thereof 
[13-15]. The t(5;ll)(q35;ql3) has been observed as sole
From the Department of Human Genetics [R. J. S., B.J., D. O, W., 
G. M., A, G.v, K.], University Hospital Nijmegen, The Netherlands; 
the Department of Medical Genetics [T. D., E, v. d. B., B. de f.L 
University of Groningen, The Netherlands; the Department of 
Pathology [E. S.], University Hospital, Leiden, The Netherlands; 
and the Southwest Biomedical Research Institute and Genzyme 
Genetics /A, M. M.], Scottsdale, Arizona, USA.
Address reprint requests to: Dr. A, Geurts van Kessel, Depart­
ment of Human Genetics, University Hospital, P. O. Box 9101, 
6500 HB Nijmegenf The Netherlands.
Received May 29, 1996; accepted Avgust 9, 1996.
Cancer Genet Cytogenet 96:95-101 (1997)
© Elsevier Scionce Inc., 1997
655 Avenue of the Americas, New York, NY 10010
cytogenetic anomaly in at least 3 independent cases and, as 
such, should be considered as a primary change. Deletion of 
3p material that occurs in the majority of renal cell carci­
nomas [16,17] has not been observed in renal oncocytomas. 
The presence of mitochondrial DNA alterations has been 
reported by some investigators [18,19]. These latter obser­
vations, however, could not be substantiated by others [20].
In view of the steadily accumulating evidence that chro­
mosomal changes play causal roles in cancer development 
[21-23], we assume that in this case, too, the chromosomal 
translocation points at a gene(s) that plays a crucial role in 
the pathogenesis of renal oncocytomas. Therefore, we ini­
tiated the fine mapping of the t(5;ll)(q35;ql3) breakpoint. 
Because band l lq l3  is involved in a variety of malignant 
disorders, including mantle cell lymphomas, squamous 
cell carcinomas, breast cancer, multiple endocrine neopla­
sia type 1, and extragonadal germ cell tumors [24-30], and 
because l lq l3  is relatively well mapped [24, 31, 32], we 
selected this region for detailed analysis. To this end, fluo­
rescence in situ hybridization (FISH) with breakpoint re­
gion-specific probes was employed. In addition, a panel of 
oncocytoma-derived interspecies somatic cell hybrids was 
generated to facilitate our studies. The resulting mapping 
data are useful (1) to construct a detailed physical map of 
the breakpoint region; and (2) to provide a basis to isolate 
the breakpoint itself and the gene[s) involved in the devel­
opment of renal oncocytomas.
MATERIALS AND METHODS 
Tumors and Somatic Cell Hybrids
Samples of the t(5;ll)(q35;ql3)-positive renal oncocytomas 
T88-1665 and T92-12439 were obtained from. 2 different
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patients after radical nephrectomy at surgery. Following dis- 
aggregation of tumor cells with collagenase and subsequent 
short-term culturing, metaphase spreads were prepared 
using standard procedures. In addition, a panel of somatic 
cell hybrids was isolated after fusion of the thymidine kinase 
deficient (tk~) Chinese hamster cell line A3 with T92-12439 
cells. Fusion and hybrid selection were performed essen­
tially as described before [33], using Sendai virus as a fuso- 
gen and a combined HAT/Ouabain procedure for selection of 
hybrid cells in which the reciprocally translocated chromo­
somes segregate, The chromosomal constitution of hybrid 
cells was evaluated by cytogenetic analysis using R-banding 
after heat dénaturation and by FISH using a combination of 
centromere-specific probes and whole-chromosome paints.
Fluorescence in Situ Hybridization
Multicolor FISH experiments were carried out as reported 
before [28, 34], In short, probe DNAs were labeled with 
biotin-14-dATP (Life Technologies, Gaithersburg, MD, USA) 
or digoxigenin-ll-dUTP (Boehringer, Mannheim, Germany) 
following nick translation, All labeled probes, except the 
alphoid probe, were subjected to preannealing to compete 
out repetitive sequences using 25- to 50-fold excess of 
Cot.l DNA (Life Technologies, Gaithersburg, MD, USA), 
For efficient hybridizations, 10 ng labeled alphoid and 200 
ng labeled cosmid probe DNAs were applied under a 20 X 
20 mm coverslip onto primary tumor or somatic cell
hybrid-derived metaphase spreads. Visualization of the 
hybridization signals was accomplished using Texas Red- 
conjugated avidin and biotinylated goat antiavidin anti­
bodies (Vector Laboratories, Burlingame, CA} USA) for 
biotin-labeled probes and fluorescein-conjugated sheep 
antidigoxigenin (Boehringer, Mannheim, Germany) and 
fluorescein-conjugated donkey antisheep antibodies (Jack­
son Immunoresearch, West Grove, PA, USA) for digoxigenin- 
labeled probes. Slides were immersed in antifade-solution, 
supplemented with 4,6-diamino-2-phenylindole (DAPI, 0.5 
|ig/mL; Sigma, St, Louis, MO, USA) for counterstaining of 
the chromosomes. Evaluation of the FISH results was per­
formed using a Zeiss Axiophot epifluorescence microscope, 
equipped for the visualization of fluorescein isothiocyan- 
ate (FITC), Texas Red, and DAPI fluorescence. Digital images 
were captured using a high-performance CH250/A cooled 
CCD-camera (Photometries, Tucson, AZ, USA) interfaced 
onto a Macintosh Quadra 950 computer. Acquisition, pro­
cessing, and display were accomplished using the BDS- 
image™ FISH software package (Oncor Imaging, Gaithers­
burg, MD, USA). Photographs were made using a Polaroid 
Quick-Print with Kodak EPP 100 Plus color slide film.
Southern Blot Analysis
High-molecular-weight DNAs were isolated as described 
before [35], digested to completion, electrophoresed dirough
0.8% agarose gels, and blotted onto Genescreen Plus nylon
Figure 1 Renal oncocytoma-derived karyotype exhibiting t(5;ll)(q35;ql3) as the sole cytogenetic abnormality 
(arrows).
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membranes (Dupont) using standard protocols. Blots were 
hybridized with probes (labeled with a-32P-dCTP by ran- 
dom priming) in 0.5 M phosphate, 1 mM Na2-EDTA, and 
7% SDS (w/v) at 65°C overnight and subsequently washed 
in  40 mM or 10 mM phosphate 0.1% SDS at 65°C.
Probes
For the FISH and Southern blot analyses we used 27 cosxnid 
and/or plasmid probes specific for chromosomes 5 and 11. 
As references in our FISH experiments we used a plasmid 
probe specific for the centromeric (alphoid) region of chro­
mosome 11 (pCLllA), and whole-chromosome painting 5- 
and 11-specific plasmid libraries pBS5 and pBSll, respec­
tively [36]. A summary of all the probes used is listed in 
Table 1 [37-39].
RESULTS AND DISCUSSION
Characterization of t(5;ll)(q35;ql3) in Primary Tumors
Cytogenetic analysis of two primary renal oncocytomas (T88- 
1665 and T92-12439) revealed the presence of t(5;ll) 
(q35;ql3) as sole anomaly (Fig. 1). These primary tumors 
were used for a more detailed characterization of the translo­
cation. Starting from the l lq l3  region, FISH analyses were 
performed on metaphase spreads obtained from short-term 
cultured primary tumor cells. Double hybridizations with 
combinations of llql3-specific cosmids (Table 1) and the 
alphoid probe (pCLllA) specific for the centromeric region 
of chromosome 11 were carried out to verify the location of 
the translocation breakpoint within this cytogenetic band. In 
both primary tumors, the cosmid probes for PGA (cgHGPl8) 
and BCLl (cCLBCLl) mapped proximal and distal to the
Figure 2 FISH analysis of primary renal oncocytoma T88-1665 (c) and oncocytoma (T92-12439)-derived 
somatic cell hybrid A30N17B (a,b,d) metaphase spreads, (a) C o sm id  clone cCI5-20 (green; arrows) in combination 
with the chromosome 11 centromere-specific probe pCLllA (red; arrowheads); cCI5~20 remains on der(5). (b) 
Cosmid clone cCI5-12 (red; arrows) in combination with pCLllA (green; arrowheads); cCl5-12 translocates to 
der(ll). (c) Cosmid clone cgHGPlS (red) in combination with cosmid clone cCLBCLl (green); split signals on 
der(ll) and der(5) (cgHGPl8 and cCLBCLl, respectively) are marked by arrows, (d) Cosmid clone cCI5-20 (red; 
arrow) in combination with whole chromosome 11 paint probe pB Sll (green); cCI5-20 remains on der(5).
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Table 1 List of chromosome 5 and 11 specific DNA probes used
Locus Probe Chromosomal
symbol name Type localization. Reference
D5S22 JQ205H-C P 5q34~qter [38]
PDGFRB RP41 P 5q33-q35 [38]
CSFlR P19F7 P 5q33~q35 [38]
ADRB2 966 P 5q31-q32 [38]
cCIS-12 C 5q35.2-q35.3 [39]
cCIS-14 C 5q35.1-q35.2 [39]
CCI5-20 C 5q34—q35.1 [39]
ccrs-30 C 5q35.2~q35.3 [39]
C C I5-37 C 5q35*l-q35.2 [39]
pBS5 P 5pter-qter [36]
D llZ l pCLllA P llc e n [38]
PGA cgHGPlB C llq l3 [38]
D11S449 cCIll-219 C Ilq l3 .1 -q l3 .2 [31]
PYGM cCLlS c U q l2 -q l3 .2 [38]
D11S546 cCIll-363 C Ilq l3 .1 -q l3 .3 [31]
3G3S2 P [28]
D11S807 CCLGW39 C Ilq l2 -q l3 .2 [38]
D11S460 cCIll-254 c Ilq l3 .1 -q l3 .3 [31]
254.3 p [28]
D11S443 cCIll-44 c I lq l3 .1 -q l3 .4 [31]
Schuuriug et al.,
no.30 p unpublished results 
Schuuring et al.,
D11S146 cCL59 c I lq l2 -q l3 .2 unpublished results
pHBl59 p [32]
Schuuring et al.,
BCLl cCLBCLl c l lq l3 .3 unpublished results
Bcilb p [32]
CCNDl B31.1 p l lq l3 [32]
pB Sll p llpter-qter [36]
Abbreviations: C, cosmici; P, plasmid.
breakpoint in l lq l3 , respectively (Fig, 2), confirming the 
position of the breakpoint within this genomic interval.
Southern Blot Analysis of Oncocytoma-Derived Somatic 
Cell Hybrids
To characterize t(5;ll)(q35;ql3) in further detail, a panel of 
somatic cell hybrids was constructed in which the recipro­
cally translocated chromosomes segregate, After fusion, 86 
independent hybrid clones were isolated, 4 of which were 
selected for further mapping purposes (Table 2): A30N4A 
and A30N16A containing der(5), A30N11A containing 
der(5) and der(ll), and A30N17B containing the normal cop­
ies of chromosomes 5 and 11 in combination with both der(5) 
and der(ll), These clones were screened for the presence 
and/or absence of a series of chromosomes 5- and 11-spe­
cific probes using Southern blot analysis (not shown). The 
markers D5S22, PDGFRB, CSFlR, and ADRB2 were found 
to map proximal to the breakpoint on chromosome 5 (pos­
itive in A30N4A and A3 ONI 6 A). Similarly, the markers 
D11S546, D11S460, D11S443, and D11S164 could be located 
proximal to the breakpoint on chromosome 11, and the 
markers BCLl and CCDNl distal to the breakpoint (Table 2). 
These results agree with and substantiate the above FISH 
results localizing BCLl (and the more distal marker 
CCNDl) telomeric to the l lq l3  breakpoint.
Table 2 Presence and/or absence of the normal and t(5;ll)-derived chromosomes and their markers in different Chinese
hamsters x renal oncocytoma somatic cell hybrids
Hybrid
done
Chromosomes
Markers0 
chromosome 5
Markers 
chromosome 11
5 11 der(5) der(ll) D5S22 PDGFRB CSFlR ADRB2 D11S546 D11S460 D11S443 D11S146 BCLl CCNDl
A30N4A — — + — + + + — — —  — + +
A30N11A — — + + + + + + + ' + +
A30N16A — — + — + + + — — —  — + +
A30N17B + + + + + + + + + +
"For details of the locus-specific probes, see Table 1.
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Figure 3 Chromosome 11 showing l lq l3  DNA markers together with the relative positions of the MENl locus 
and the extragonadal germ cell tumor-and the renal oncocytoma-associated translocation breakpoints.
FISH Analysis of Oncocytoma-Derived Somatic Cell 
Hybrids
Because of lack of primary tumor-derived metaphase spreads 
we subsequently made use of hybrid cell line A30N17B 
{Table 2), containing the normal copies of chromosomes 5 
and 11 in addition to its translocation derivatives der(5) 
and der(ll), respectively, for further FISH analysis. To this 
end, five 5q34-q35—specific cosmid probes (Table 1) were 
used. Of these, only cCl5-20 hybridized to the der(5) chro­
mosome, whereas the other four cosmids, cCl5-12, cCI5-14, 
cCI5-30, and cCI5-37, hybridized to der(ll), that is map dis­
tal to the breakpoint (Fig. 2). These results confirm our previ­
ous cytogenetic localization of the t(5;ll) breakpoint within 
band 5q35. By using an additional series of chromosome 11- 
specific cosmids (Table 1), the localization of the llq l3  
breakpoint between the markers D11S146 and BCLl could, 
again, be confirmed (i.e., cosmids cCIll-219, cCLlS, cCUl- 
363, cCLGW39, cGIl 1-254, cCIll-44, and cCL59 map proxi­
mal, and cCLBCLl maps distal to the breakpoint).
Taken together, our results indicate that die oncocytoma- 
specific l lq l3  breakpoint is flanked by two chromosomal 
regions that are frequently affected in (1) multiple endo­
crine neoplasia type 1 (MENl) and extragonadal germ cell 
tumors (proximal) and (2) mantle cell lymphomas (BCLl; 
distal) (Fig. 3). A physical map encompassing the markers 
D11S443, D11S146, BCLl, and CCNDl has been con­
structed using pulse field gel electrophoresis [31] and 
somatic cell hybrid [32] analyses. Based on these mapping 
data, the physical distance between D11S443/D11S146 and 
BCLl was estimated to measure between 350 and 550 kb.
Recently, this distance between these loci was more pre­
cisely determined using Fibre-FISH (380-400 kb) [Schuur- 
ing et al., unpublished results]. Based on these compiled 
mapping data, several candidate genes located in the H ql3  
region, that is, PPPla, PLCp3, FOSLl, SEA, PYGM, FGF3, 
FGF4, EMSl, and GSTt [27, 34, 36] can be excluded from 
being involved in the development of t(5 ;ll)(q35;ql3)— 
positive oncocytomas. It remains to be established whether 
the expression of CCNDl is affected by the translocation.
In conclusion, we have located the renal oncocytoma- 
specific chromosomal breakpoint in band l lq l3  within an 
interval of at maximum 400 kb flanked by the markers 
D11S443/D11S146 and BCLl. This information should (1) 
pave the way for the positional cloning of this specific 
translocation breakpoint and the identification of the 
gene(s) involved in the development of these tumors; and
(2) provide molecular tools for the discrimination between 
oncocytomas and other (malignant) renal neoplasms. Fur­
thermore, because rearrangements of l lq l3  also can be en­
countered in other RCCs, the availability of breakpoint- 
specific probes will be instrumental in establishing to what 
extent relationship(s) do exist among these neoplasms at 
the molecular level [7].
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